START Madrid, Hospital Universitario Fundacion Jimenez Diaz

Madrid 28040

5 studies enrolling now · 11 studies all time

What they study most

Acral Melanoma, Advanced Breast Cancer, Advanced Solid Tumor, Advanced or Metastatic NSCLC, Basal Cell Carcinoma, Bladder Cancer, Breast Cancer, Cancer With A High Tumor Mutational Burden, Cervical Cancer, Cervical Cancers, Clear Cell Renal Cell Carcinoma, Colorectal Cancer

Studies at this site

• A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer — Recruiting now
• A Study of GEN1106 in Participants With Solid Tumors — Recruiting now
• A Study of ZW251 in Participants With Advanced Solid Tumors — Recruiting now
• Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors — Recruiting now
• A Beta-only IL-2 ImmunoTherapY Study — Recruiting now
• GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors — Running, not enrolling
• First-in-Human Study of TAK-280 in Participants With Solid Tumors — Stopped early
• Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02) — Running, not enrolling
• A Study of HMPL-306 in Advanced Hematological Malignancies With mIDH — Stopped early
• ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer — Running, not enrolling
• HER-Seq: A Blood-based Screening Study to Identify Patients With HER2 Mutations for Enrollment Into Clinical Research Studies of Neratinib — Stopped early